Markets Earnings Screener Watchlist

Fundamentals and filings are sourced from SEC EDGAR. Market data, ownership and analyst consensus are sourced from Nasdaq. Written analysis is generated by metir from those sources and the linked reporting.

All information is provided for informational purposes only. It is not investment, financial, tax or legal advice, is not a recommendation to buy or sell any security, and is not intended for trading purposes. Data may be delayed or incomplete.

Philip Morris International Inc Stock Price: Quote, Financials, Forecast & News (PM)

Markets open

Philip Morris International Inc

PM · NYSE

Overview Financials Earnings Holders Historical Data Analysis

$189.50+$2.661.43%

As of: Aug 5, 6:01 PM

Prev Close: $186.91
Market Cap: $295.35B
Open: —
Trailing P/E: —
Day Range: $189.69 - $185.50
52W Range: $207.76 - $142.11
Forward P/E: —
EPS: —
Volume: 2.59M
Dividend Yield: —

Notable Price Movement

Weekly movement commentary will appear here once it has been generated for this company.

Stories & Analysis

See Which Recent 13F Filers Hold PM

BNK Invest · 2d ago

Can Altria's Pricing Power Offset Cigarette Volume Declines?

Zacks · 2d ago

Noteworthy ETF Inflows: SPMO, PM, KO, BNY

BNK Invest · 2d ago

Tuesday Sector Leaders: Cigarettes & Tobacco, Paper & Forest Products

BNK Invest · Jul 28

PMI Launches $1.2B Aurora Facility, Expands ZYN Production

RTTNews · Jul 28 ACWI, PM, GEV, C: Large Outflows Detected at ETF

BNK Invest · Jul 24 Philip Morris Trimmed Guidance, But Its Growth Story Looks Unshaken

MarketBeat · Jul 23 Company News for July 23, 2026

Zacks · Jul 23

Symbol: PM
Type: Stock
Sector: Health Care
Industry: Medicinal Chemicals and Botanical Products
Country: North America
Exchange: NYSE

Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105 markets, and as of December 31, 2025, PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 43% of PMI's first-quarter 2026 total net revenues. Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes.

Analyst Consensus

Buy

15 analysts

$189

Current

—

Low

$211

Average

—

High

Average target implies +11.35% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Novartis AGNVS · NYSE$154.41

0.74%

Merck & Company, Inc.MRK · NYSE$128.840.66%

AstraZeneca PLC Ordinary SharesAZN · NYSE$161.543.80%

Amgen Inc.AMGN · NASDAQ-GS$406.514.23%

Beta

—

Avg Volume

4.50M